Abstract
Objective
The purpose of this study was to assess retrospectively the characteristics of FDG uptake in elastofibroma dorsi using integrated PET/CT.
Methods
From 10,261 oncology FDG-PET/CT scans performed over a 2-year period, findings suggestive of elastofiboma dorsi were observed in 46 FDG-PET/CT scans of 34 patients. As 20 patients had bilateral lesions and 14 had unilateral lesions, a total of 75 elastofibroma dorsi lesions on images were identified in this study. For visual analysis of intensity of FDG uptake , a four-point grading system was used: grade 0 for no uptake, grade 1 for less uptake than the liver, grade 2 for uptake comparable to the liver, and grade 3 for intense uptake greater than the liver. For quantitative analysis, the standardized uptake value (SUV) was calculated. The relationships between SUV and age, blood glucose level, lesion size, and related symptoms were also assessed.
Results
Among the 75 lesions, 4 had an uptake grade of 0, 41 had grade 1, 25 had grade 2, and 5 had grade 3. The mean SUV (±SD) of the 75 lesions was 2.0 ± 0.63 (range 0–5.1). The Pearson correlation coefficient test indicated a weak positive correlation between SUV and lesion size and no correlation between SUV and either age or blood glucose level. The SUVs of patients with symptoms due to the disease and patients without symptoms were almost the same.
Conclusion
Mild and moderate uptake of FDG is frequently observed in elastofibroma dorsi, which should not be misinterpreted as abnormal accumulation observed in malignant lesions.
Similar content being viewed by others
References
Patrikeos A, Breidahl W, Robins P. F-18 FDG uptake associated with elastofibroma dorsi. Clin Nucl Med. 2005;30:617–18.
Wasyliw CW, Caride VJ. Incidental detection of bilateral elastofibroma dorsi with F-18 FDG PET/CT. Clin Nucl Med. 2005;30:700–1.
Pierce JC III, Henderson R. Hypermetabolism of elastofibroma dorsi on PET-CT. AJR. 2004;183:35–7.
Jarvi OH, Lansimies PH. Subclinical elastofibromas in the scapular region in an autopsy series. Acta Pathol Microbiol Scand A. 1975;83:87–108.
Nagamine N, Nohara Y, Ito E. Elastofibroma in Okinawa. A clinicopathologic study of 170 cases. Cancer. 1982;50:1794–805.
Naylor MF, Nascimento AG, Sherrick AD, Mcleod RA. Elastofibroma dorsi: radiologic findings in 12 patients. AJR. 1996;167:683–7.
Brandser EA, Goree JC, El-Khoury GY. Elastofibroma dorsi: prevalence in an elderly patient population as revealed by CT. AJR Am J Roentgenol. 1998;171:977–80.
Guha AR, Raja RCS. Elastofibroma dorsi—a case report and review of literature. Int J Clin Pract. 2004;58:218–20.
Oueslati S, Douira-Khomsi W, Bouaziz MC, Zaouia K. Elastofibroma dorsi: a report on 6 cases. Acta Orthop Belg. 2006;72:237–42.
Muratori F, Esposito M, Rosa F, et al. Elastofibroma dorsi: 8 case reports and a literature review. J Orthopaed Traumatol. 2008;9:33–7.
Battaglia M, Vanel D, Pollastri P, et al. Imaging patterns in elastofibroma dorsi. Eur J Radiol. 2009;72:16–21.
Shick S, Zembsch A, Gahleitner A, et al. Atypical appearance of elastofibroma dorsi on MRI: case reports and review of the literature. J Comput Assist Tomogr. 2000;24:288–92.
Acknowledgments
We thank Hiroyoshi Okajima, Keita Miyamoto, Eiji Takeda, and Kazuhiro Kubo for their excellent technical assistance and generous support.
Conflicts of interest
The authors declare that there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Onishi, Y., Kitajima, K., Senda, M. et al. FDG-PET/CT imaging of elastofibroma dorsi. Skeletal Radiol 40, 849–853 (2011). https://doi.org/10.1007/s00256-010-1057-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00256-010-1057-3